Metabolic syndrome and risk of Parkinson disease

A nationwide cohort study

Ga Eun Nam, Seon Mee Kim, Kyungdo Han, Nan Hee Kim, Hye Soo Chung, Jin Wook Kim, Byoungduck Han, Sung Jung Cho, Ji Hee Yu, Yong Gyu Park, Kyung Mook Choi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: The association of metabolic syndrome (MetS) with the development of Parkinson disease (PD) is currently unclear. We sought to determine whether MetS and its components are associated with the risk of incident PD using large-scale cohort data for the whole South Korean population. Methods and findings: Health checkup data of 17,163,560 individuals aged ≥40 years provided by the National Health Insurance Service (NHIS) of South Korea between January 1, 2009, and December 31, 2012, were included, and participants were followed up until December 31, 2015. The mean follow-up duration was 5.3 years. The hazard ratio (HR) and 95% confidence interval (CI) of PD were estimated using a Cox proportional hazards model adjusted for potential confounders. We identified 44,205 incident PD cases during follow-up. Individuals with MetS (n = 5,848,508) showed an increased risk of PD development compared with individuals without MetS (n = 11,315,052), even after adjusting for potential confounders including age, sex, smoking, alcohol consumption, physical activity, income, body mass index, estimated glomerular filtration rate, and history of stroke (model 3; HR, 95% CI: 1.24, 1.21–1.27). Each MetS component was positively associated with PD risk (HR, 95% CI: 1.13, 1.10–1.16 for abdominal obesity; 1.13, 1.10–1.15 for hypertriglyceridemia; 1.23, 1.20–1.25 for low high-density lipoprotein cholesterol; 1.05, 1.03–1.08 for high blood pressure; 1.21, 1.18–1.23 for hyperglycemia). PD incidence positively correlated with the number of MetS components (log-rank p < 0.001), and we observed a gradual increase in the HR for incident PD with increasing number of components (p < 0.001). A significant interaction between age and MetS on the risk of incident PD was observed (p for interaction < 0.001), and people aged ≥65 years old with MetS showed the highest HR of incident PD of all subgroups compared to those <65 years old without MetS (reference subgroup). Limitations of this study include the possibilities of misdiagnosis of PD and reverse causality. Conclusions: Our population-based large-scale cohort study suggests that MetS and its components may be risk factors of PD development.

Original languageEnglish
Article numbere1002640
JournalPLoS Medicine
Volume15
Issue number8
DOIs
Publication statusPublished - 2018 Aug 1

Fingerprint

Parkinson Disease
Cohort Studies
National Health Programs
Confidence Intervals
Proportional Hazards Models
Republic of Korea
Abdominal Obesity
Hypertriglyceridemia
Diagnostic Errors
Glomerular Filtration Rate
Hyperglycemia
Alcohol Drinking
Causality
LDL Cholesterol
HDL Cholesterol
Population
Body Mass Index
Smoking
Stroke
Odds Ratio

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Metabolic syndrome and risk of Parkinson disease : A nationwide cohort study. / Nam, Ga Eun; Kim, Seon Mee; Han, Kyungdo; Kim, Nan Hee; Chung, Hye Soo; Kim, Jin Wook; Han, Byoungduck; Cho, Sung Jung; Yu, Ji Hee; Park, Yong Gyu; Choi, Kyung Mook.

In: PLoS Medicine, Vol. 15, No. 8, e1002640, 01.08.2018.

Research output: Contribution to journalArticle

Nam, Ga Eun ; Kim, Seon Mee ; Han, Kyungdo ; Kim, Nan Hee ; Chung, Hye Soo ; Kim, Jin Wook ; Han, Byoungduck ; Cho, Sung Jung ; Yu, Ji Hee ; Park, Yong Gyu ; Choi, Kyung Mook. / Metabolic syndrome and risk of Parkinson disease : A nationwide cohort study. In: PLoS Medicine. 2018 ; Vol. 15, No. 8.
@article{7b15d9285a83403a96a3a9b30b763293,
title = "Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study",
abstract = "Background: The association of metabolic syndrome (MetS) with the development of Parkinson disease (PD) is currently unclear. We sought to determine whether MetS and its components are associated with the risk of incident PD using large-scale cohort data for the whole South Korean population. Methods and findings: Health checkup data of 17,163,560 individuals aged ≥40 years provided by the National Health Insurance Service (NHIS) of South Korea between January 1, 2009, and December 31, 2012, were included, and participants were followed up until December 31, 2015. The mean follow-up duration was 5.3 years. The hazard ratio (HR) and 95{\%} confidence interval (CI) of PD were estimated using a Cox proportional hazards model adjusted for potential confounders. We identified 44,205 incident PD cases during follow-up. Individuals with MetS (n = 5,848,508) showed an increased risk of PD development compared with individuals without MetS (n = 11,315,052), even after adjusting for potential confounders including age, sex, smoking, alcohol consumption, physical activity, income, body mass index, estimated glomerular filtration rate, and history of stroke (model 3; HR, 95{\%} CI: 1.24, 1.21–1.27). Each MetS component was positively associated with PD risk (HR, 95{\%} CI: 1.13, 1.10–1.16 for abdominal obesity; 1.13, 1.10–1.15 for hypertriglyceridemia; 1.23, 1.20–1.25 for low high-density lipoprotein cholesterol; 1.05, 1.03–1.08 for high blood pressure; 1.21, 1.18–1.23 for hyperglycemia). PD incidence positively correlated with the number of MetS components (log-rank p < 0.001), and we observed a gradual increase in the HR for incident PD with increasing number of components (p < 0.001). A significant interaction between age and MetS on the risk of incident PD was observed (p for interaction < 0.001), and people aged ≥65 years old with MetS showed the highest HR of incident PD of all subgroups compared to those <65 years old without MetS (reference subgroup). Limitations of this study include the possibilities of misdiagnosis of PD and reverse causality. Conclusions: Our population-based large-scale cohort study suggests that MetS and its components may be risk factors of PD development.",
author = "Nam, {Ga Eun} and Kim, {Seon Mee} and Kyungdo Han and Kim, {Nan Hee} and Chung, {Hye Soo} and Kim, {Jin Wook} and Byoungduck Han and Cho, {Sung Jung} and Yu, {Ji Hee} and Park, {Yong Gyu} and Choi, {Kyung Mook}",
year = "2018",
month = "8",
day = "1",
doi = "10.1371/journal.pmed.1002640",
language = "English",
volume = "15",
journal = "PLoS Medicine",
issn = "1549-1277",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Metabolic syndrome and risk of Parkinson disease

T2 - A nationwide cohort study

AU - Nam, Ga Eun

AU - Kim, Seon Mee

AU - Han, Kyungdo

AU - Kim, Nan Hee

AU - Chung, Hye Soo

AU - Kim, Jin Wook

AU - Han, Byoungduck

AU - Cho, Sung Jung

AU - Yu, Ji Hee

AU - Park, Yong Gyu

AU - Choi, Kyung Mook

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Background: The association of metabolic syndrome (MetS) with the development of Parkinson disease (PD) is currently unclear. We sought to determine whether MetS and its components are associated with the risk of incident PD using large-scale cohort data for the whole South Korean population. Methods and findings: Health checkup data of 17,163,560 individuals aged ≥40 years provided by the National Health Insurance Service (NHIS) of South Korea between January 1, 2009, and December 31, 2012, were included, and participants were followed up until December 31, 2015. The mean follow-up duration was 5.3 years. The hazard ratio (HR) and 95% confidence interval (CI) of PD were estimated using a Cox proportional hazards model adjusted for potential confounders. We identified 44,205 incident PD cases during follow-up. Individuals with MetS (n = 5,848,508) showed an increased risk of PD development compared with individuals without MetS (n = 11,315,052), even after adjusting for potential confounders including age, sex, smoking, alcohol consumption, physical activity, income, body mass index, estimated glomerular filtration rate, and history of stroke (model 3; HR, 95% CI: 1.24, 1.21–1.27). Each MetS component was positively associated with PD risk (HR, 95% CI: 1.13, 1.10–1.16 for abdominal obesity; 1.13, 1.10–1.15 for hypertriglyceridemia; 1.23, 1.20–1.25 for low high-density lipoprotein cholesterol; 1.05, 1.03–1.08 for high blood pressure; 1.21, 1.18–1.23 for hyperglycemia). PD incidence positively correlated with the number of MetS components (log-rank p < 0.001), and we observed a gradual increase in the HR for incident PD with increasing number of components (p < 0.001). A significant interaction between age and MetS on the risk of incident PD was observed (p for interaction < 0.001), and people aged ≥65 years old with MetS showed the highest HR of incident PD of all subgroups compared to those <65 years old without MetS (reference subgroup). Limitations of this study include the possibilities of misdiagnosis of PD and reverse causality. Conclusions: Our population-based large-scale cohort study suggests that MetS and its components may be risk factors of PD development.

AB - Background: The association of metabolic syndrome (MetS) with the development of Parkinson disease (PD) is currently unclear. We sought to determine whether MetS and its components are associated with the risk of incident PD using large-scale cohort data for the whole South Korean population. Methods and findings: Health checkup data of 17,163,560 individuals aged ≥40 years provided by the National Health Insurance Service (NHIS) of South Korea between January 1, 2009, and December 31, 2012, were included, and participants were followed up until December 31, 2015. The mean follow-up duration was 5.3 years. The hazard ratio (HR) and 95% confidence interval (CI) of PD were estimated using a Cox proportional hazards model adjusted for potential confounders. We identified 44,205 incident PD cases during follow-up. Individuals with MetS (n = 5,848,508) showed an increased risk of PD development compared with individuals without MetS (n = 11,315,052), even after adjusting for potential confounders including age, sex, smoking, alcohol consumption, physical activity, income, body mass index, estimated glomerular filtration rate, and history of stroke (model 3; HR, 95% CI: 1.24, 1.21–1.27). Each MetS component was positively associated with PD risk (HR, 95% CI: 1.13, 1.10–1.16 for abdominal obesity; 1.13, 1.10–1.15 for hypertriglyceridemia; 1.23, 1.20–1.25 for low high-density lipoprotein cholesterol; 1.05, 1.03–1.08 for high blood pressure; 1.21, 1.18–1.23 for hyperglycemia). PD incidence positively correlated with the number of MetS components (log-rank p < 0.001), and we observed a gradual increase in the HR for incident PD with increasing number of components (p < 0.001). A significant interaction between age and MetS on the risk of incident PD was observed (p for interaction < 0.001), and people aged ≥65 years old with MetS showed the highest HR of incident PD of all subgroups compared to those <65 years old without MetS (reference subgroup). Limitations of this study include the possibilities of misdiagnosis of PD and reverse causality. Conclusions: Our population-based large-scale cohort study suggests that MetS and its components may be risk factors of PD development.

UR - http://www.scopus.com/inward/record.url?scp=85053280697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053280697&partnerID=8YFLogxK

U2 - 10.1371/journal.pmed.1002640

DO - 10.1371/journal.pmed.1002640

M3 - Article

VL - 15

JO - PLoS Medicine

JF - PLoS Medicine

SN - 1549-1277

IS - 8

M1 - e1002640

ER -